Drug intelligence / Profile preview

fibrin sealant (Sichuan Yuanda Shuyang Pharmaceutical)

Development stage
Unknown
Lead developer
Grand Shuyang Life Sciences
Modality
Recombinant Proteins and Enzymes
Administration
Topical
01

Overview

Human fibrin sealant is a topical hemostatic agent and tissue adhesive derived from human plasma, designed to facilitate wound closure and control bleeding during surgical procedures. It is a combination product typically consisting of two primary components: a concentrated fibrinogen solution (which often includes coagulation factor XIII) and a thrombin solution. When applied to a surgical site, the thrombin catalyzes the conversion of fibrinogen into fibrin, mimicking the final stage of the physiological coagulation cascade to form a stable, insoluble fibrin clot. This clot adheres to the tissue, providing a physical barrier that promotes hemostasis and supports tissue sealing. Sichuan Yuanda Shuyang Pharmaceutical is developing a human fibrin sealant kit, which is currently being evaluated in Phase 3 clinical trials (e.g., CTR20254119) for its efficacy and safety in achieving local hemostasis during hepatic surgery.

Brand names
Colla di Fibrina Kedrion
Other names
human fibrin sealanthuman fibrin sealant kit人纤维蛋白粘合剂
02

Targets

Protease-activated receptor 1 and Protease-activated receptor 4Wound-surface extracellular matrix proteins and plateletsCoagulation Factor XIIIFibrin (Factor Ia)

Beyond the preview

Go deeper on fibrin sealant (Sichuan Yuanda Shuyang Pharmaceutical).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on fibrin sealant (Sichuan Yuanda Shuyang Pharmaceutical).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call